Related Experiment Video
Updated: May 21, 2026

Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining
Published on: March 17, 2023
Not Just Jaundice: Furosemide-Induced Yellow-Tinted Vision in Decompensated Liver Cirrhosis
Kimberly Ho1, Casey Reed1, Alex Chang1
1Department of Medicine, Brown University Health, Providence, RI.
Abstract:
Xanthopsia, a yellow-tinted visual disturbance, is a rarely reported adverse effect of furosemide. We present the case of a 45-year-old man with alcohol-related cirrhosis who developed reversible xanthopsia shortly after initiating furosemide for ascites management. Symptoms resolved on discontinuation of the drug. This case highlights a rare but important potential side effect of a commonly prescribed loop diuretic, particularly in patients with hepatic dysfunction, where altered pharmacokinetics may increase toxicity risk. Clinicians should maintain vigilance for visual symptoms when prescribing furosemide, especially in patients with renal and liver dysfunction.
Related Concept Videos
Jaundice
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cirrhosis II: Pathophysiology

